01:01:34

Repurposing Virus Specific T cells as Immune Therapy for Osteosarcoma

58:59

Repurposing Drugs for Osteosarcoma

01:06:17

The ablative and immunomodulatory effects of histotripsy treatment in osteosarcoma

58:22

osTEAo: Spooky Sarcoma Stories

01:01:07

Molecular and cellular deconstruction of metastatic osteosarcoma

53:18

osTEAo: Back to School: Cancer + Curriculum

00:48

Penelope - Bows

12:10

OutSmarting Osteosarcoma 2025 Overview

01:00:03

Fit for Filing Academic Clinical Trials: An Industry Perspective

01:02:13

High Intensity Focused Ultrasound (HIFU) For Palliation of Canine Appendicular Osteosarcoma

59:01

osTEAo - Clear Scans…So Now What?

59:54

Clinical Utility of Functional Precision Medicine to Guide Treatments for Osteosarcoma Patients

01:15

FACTOR 2024 Highlights

57:14

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy

57:49

A Multi-Institution Study in Combination with Relapsed or Refractory Pediatric Bone and Soft Tissue

01:04:44

osTEAo: The Sibling Situation

01:05:02

Genomes, Avatars and AI: The Future of Personalized Medicine

01:02:23

Exploring Novel Immunotherapies for Canine Osteosarcoma

03:51

Learn more about MIB Agents

01:05:09

A Guide to the FACTOR 2024 Scientific Panels with Matteo Trucco, MD

01:26:34

osTEAo: Long Term Side Effects from Treatment For Osteosarcoma and AYA Cancer

01:04:01

Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project

00:21

Day of Giving Thank You!

01:01:24

Positioning Poly-(ADP)-ribose polymerase inhibitors (PARPi) for the treatment of Osteosarcoma

01:35

MIB Day of Giving

00:11

Day of Giving - Luke

57:26

TGF-beta inhibition as a novel therapeutic option in Osteosarcoma

02:57

MIB Agents Giving Day 2024 May 2nd

01:29:30

Out on a Limb - Travel Tips for AYA Cancer Patients

57:19

Cabozantinib in Combo with Topotecan-Cyclophosphamide for Patients with Relapsed Osteosarcoma or EWS

46:24

Targeting Urea Cycle Dysfunction to Prevent and Treat Osteosarcoma Metastasis

01:16:13

osTEAo: Patient Experiences with Lung Surgery for Osteosarcoma

01:04:45

Osteosarcoma Explorer: Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research

01:02:57

Patient perspectives on participating in research and clinical trials

01:04:21

Tissue Engineering Strategies for Elucidating Osteosarcoma Biology and Drug Discovery

01:01:05

Liquid biopsy in Ewing sarcoma and osteosarcoma as a prognostic and response diagnostic

00:43

You Belong at FACTOR 2024!

37:50

osTEAo: Managing Stress in AYA Cancer Patients

01:00:32

Prevention of Cisplatin-induced Hearing Loss: Implications for Young People Treated for Osteosarcoma

59:55

TACOS: A Phase 2 Trial of Atezolizumab and Cabozantinib in OsteoSarcoma

01:14

MIB Agents OsteoBites webinar series

47:36

osTEAo: Making friends after a cancer diagnosis

01:00:03

Interventions to promote physical function during and after treatment for osteosarcoma

01:09

Giving 2023

36:44

The Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan (CAUSAL) study

58:45

Developing a Multiscale Transcriptional Atlas of Sarcoma

59:05

Immunological Mechanisms of Cancer Defense

01:05:49

osTEAo: Long Term Osteosarcoma Survivors: Where They Were and Where They Are Now

01:03:27

Cabozantinib as a Maintenance Therapy to Prevent Recurrence of High-Risk Pediatric Solid Tumors

13:06

The OutSmarting Osteosarcoma Research Grant Program

01:18

MIB TURBO

01:09

MIB Outsmarting

59:44

osTEAo - Coping with Cancer through Music

55:40

OsteoBites Preguntas & Respuestas con Nino Rainusso, MD

59:59

TCF-001 TRACK : A Clinical Trial Studying Precision Medicine in Rare Cancers

59:51

Repurposing Disulfiram to Overcome Chemotherapy Resistance in Relapsed Sarcomas

01:00:59

osTEAo Tea Spill: AYA Cancer Gab Sesh

58:04

Addressing Unmet Scientific Challenges in Osteo Treatment through Innovative Engineering Techniques

01:03:02

Implementing Multi-Targeted Tyrosine Kinase Inhibitors in Combination with Chemo for Osteosarcoma

01:02:05

Immune Therapies in EGFR-Expressing Cancers